Shandong Sito Biotechnology Co., Ltd. logo

Shandong Sito Biotechnology Co., Ltd. (300583)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
12. 87
-0.16
-1.2279%
¥
2.85B Market Cap
- P/E Ratio
0.04% Div Yield
2.99M Volume
- Eps
¥ 13.03
Previous Close
Add Transaction
Day Range
12.8 13.09
Year Range
10.63 18.77
Want to track 300583 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300583 closed today lower at ¥12.87, a decrease of -1.2279% from yesterday's close, completing a monthly increase of 15.2193% or ¥1.7. Over the past 12 months, 300583 stock lost -6.1953%.
300583 pays dividends to its shareholders, with the most recent payment made on Jul 14, 2026. The next estimated payment will be in In 5 months on Jan 14, 2027 for a total of ¥0.00506.
The last earnings report, released on Jun 20, 2025, missed the consensus estimates by -0.145%. On average, the company has fell short of earnings expectations by -0.0644%, based on the last three reports.
Shandong Sito Biotechnology Co., Ltd. has completed 1 stock splits, with the recent split occurring on Aug 25, 2023.
The company's stock is traded on one exchange.

300583 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Shandong Sito Biotechnology Co., Ltd. (300583) FAQ

What is the stock price today?

The current price is ¥12.87.

On which exchange is it traded?

Shandong Sito Biotechnology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300583.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.04%.

What is its market cap?

As of today, the market cap is 2.85B.

Has Shandong Sito Biotechnology Co., Ltd. ever had a stock split?

Shandong Sito Biotechnology Co., Ltd. had 1 splits and the recent split was on Aug 25, 2023.

Shandong Sito Biotechnology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Lianbiao Jin CEO
XSHE Exchange
CNE100002F36 ISIN
CN Country
959 Employees
14 Jul 2026 Last Dividend
25 Aug 2023 Last Split
- IPO Date

Overview

Shandong Sito Bio-technology Co., Ltd., founded in 2002 and based in Heze, China, is at the forefront of researching and developing new steroid biomedicine intermediates. The company dedicates itself to the creation of sophisticated biochemical products that serve a variety of medical and scientific purposes, particularly in the realm of steroid biomedicine. These efforts underscore Shandong Sito Bio-technology's commitment to advancing healthcare solutions through innovative biotechnological research.

Products and Services

  • 9a-Hydroxyandrostenedione:

    This is a steroid intermediate used in the synthesis of various pharmaceuticals, indicating its pivotal role in the development of treatments involving steroid hormones.

  • 17a-Hydroxyprogesterone:

    A critical intermediate for the production of steroid medications, particularly those involved in hormone therapy and reproductive health.

  • 17a-Hydroxy Progesterone Derivatives:

    These derivatives are significant for their applications in synthesizing a wide range of steroid-based drugs, showcasing the versatility of Shandong Sito Bio-technology's product range.

  • Anecort Acetate:

    Plays a role in manufacturing corticosteroid medications, which are essential for treating a variety of conditions including inflammation, allergies, and autoimmune diseases.

  • Neomycin Sulfate:

    An antibiotic used to prevent or treat bacterial infections, highlighting Shandong Sito Bio-technology's involvement in producing components critical to antibiotic medications.

  • Progesterone Intermediate:

    This intermediate is key in producing progesterone-based therapies, which are important in reproductive medicine among other uses.

  • Tetraene:

    Often used in antifungal medications, tetraene illustrates the company's commitment to contributing to treatments against fungal infections.

  • Androstenedione:

    This is a precursor in the biosynthesis of estrogens and androgens, showcasing the company’s role in the production of hormone therapies and supplements.

  • Ketal, 3-Ketal:

    These compounds are intermediates often used in the synthesis of other more complex steroids, illustrating the foundational aspect of Shandong Sito Bio-technology's offerings.

  • Norandrostenedione:

    A steroid precursor used in the manufacture of some anabolic steroids, pointing to the company's role in sports medicine and hormone therapy sectors.

  • Betamethasone Epoxy Hydrolyzate:

    This intermediate is used in producing potent steroid medications for conditions like dermatological diseases, rheumatic disorders, and other inflammatory conditions.

  • 1,4-Androstenedione:

    An important steroid hormone intermediate, indicative of the company’s involvement in facilitating the production of hormonal drugs and treatments.

Contact Information

Address: South section of East Outer Ring Road,, Heze City, China, 274100
Phone: 86 53 0226 3536